New York City State Medical Marijuana Program

The NYS Department of Health prompts all New Yorkers to stop using vape products till the conclusive reason for reported vaping-associated serious pulmonary (lung) health problems nationwide can be better determined. Since the investigation into the diseases began, there have been no reports of adverse events associated with authorized items in the NYS Medical Marijuana Program related to the outbreak. Medical cannabis products are authorized by the Department and rigorously evaluated for pollutants, pesticides and concentration of cannabinoids, consisting of, however not limited to Tetrahydrocannabinol (THC) and Cannabidiol (CBD). However, out of an abundance of caution, we are also prompting patients in the medical cannabis program to seek advice from their healthcare companies on possible alternatives to vaping items while the investigation continues.

To find out more about vaping-associated illnesses, click on this link.

Medicaid Policy Clarification Issued Regarding Coverage for Office Visits with Medicaid Participating Providers Related to Medical Marijuana:

Medical cannabis items are not a covered benefit under New York State Medicaid. However, specialist workplace gos to related to patient assessment and certification for medical cannabis are Medicaid reimbursable services. Practitioners who take part with Medicaid are prohibited from requesting payment for Medical Marijuana Evaluation Near Me cannabis certification from the member, regardless of whether the certification is supplied during the preliminary workplace see or subsequent to the initial visit. Patients guaranteed with Medicaid who use out-of-network or non-Medicaid service providers for evaluation and accreditation may still be charged a fee for the examination and accreditation visit. To prevent confusion, patients are encouraged to verify that their evaluating and accrediting professional participates with Medicaid prior to their consultation.